Table 2.
Groups | No. oocytes | No. (mean ± SEM%) MII oocytes | No. (mean ± SEM%) ≥ two-cell embryos | No. (mean ± SEM%) blastocysts |
---|---|---|---|---|
0 ng/mL | 242 | 160 (66.12 ± 2.04)a | 111 (69.40 ± 1.03)a | 33 (20.63 ± 1.32)a |
50 ng/mL | 256 | 172 (67.18 ± 1.52)ab | 121 (70.34 ± 1.14)a | 38 (22.09 ± 1.14)ab |
100 ng/mL | 238 | 174 (73.11 ± 1.38)c | 136 (78.16 ± 0.93)b | 45 (28.16 ± 1.67)c |
200 ng/mL | 261 | 180 (69.73 ± 1.84)b | 132 (73.32 ± 0.88)c | 40 (22.22 ± 1.02)ab |
Six replicates were performed and approximately 40 cumulus–ooctye complexes (COCs) per replicate were used for each group. Numbers in parentheses were development rates (mean ± SEM%), whereas other numbers were total oocytes or embryos number of six replicates among groups.
Development rates of two-cell embryos and blastocysts were the percent of total metaphase II (MII) oocytes and were monitored at 48 and 168 h of culture, respectively (0 h being the time embryos were transferred to G1.5 medium).
Values with different superscripts within columns are significantly different from each other (p < 0.05).
BMP6, bone morphogenetic protein 6; SEM, standard error of the mean.